CYDY will be over $30 by next week $150 by end of the year

And there's another 50% gain. It's a good time to be a CYDY investor.

25% correction from 500% gain after CD12 approval next week. Then nasdaq takes it up another 300% from there. Then pdufa PR moves it up another 100% , then longhaulers...well you get the idea

BP is big pharma not Bruce Patterson. Is it February 31st yet? The FDA is doing just the opposite of blocking CytoDyn, the FDA approved OLE and eIND. They did this because they plan to approve EUA next week.

What does it mean when an established company post multiple job openings only days after one of their accounts unblinded data from their clinical trial?

"Search for Jobs" https://americanregent.wd1.myworkdayjobs.com/American_Regent_Careers

CD12 APPROVAL-NASDAQ UPLIST-PDUFA DATE

The writing is on the wall, don't blink

They will sell shares into nasdaq after approval. Anyone would be a fool not to take some profit at $100 a share.

That's right, there will be alot of profit taking when CYDY hits $100 after approval. CytoDyn will undoubtedly take profit along with the rest of us.

Its pretty obvious nasdaq uplist has been on hold waiting on an approval. Now that CD12 is unblinded CytoDyn is hiring a paralegal. Looks like two big PR's coming up. Makes much more sense than.......a stooge

Paralegal... nasdaq uplist???

https://www.fox8jobs.com/jobs/paralegal-vancouver-washington/237516631-2/

WOW!.. "has filed a BLA with the FDA and, if approved, commercial sales could commence in early 2021."

You also told us they were looking at mortality out to February 31

CYDY UP OVER 5% TODAY

Also another factor that could have changed CytoDyn's approach to PR's is they now have guidance from Mahboob Rahman. He brings much more experience dealing with the FDA.

Not only is it only for entertainment no author signed their name to this lie. Why is the person who wrote this hiding?? Even seeking alpha which is garbage puts a name to their articles. Buyers strike is complete and total fiction, a lie written by a coward so frightened they won't sign their name to it.

How is this proof of anything? This blog clearly states in the disclaimer "this blog is for entertainment purposes only"

Those are impressive numbers. Leronlimab will save many lives.

You left out a couple of very important facts. The FDA gave approval for OLE and eIND. This is a sign that points to approval. "THE FDA review right now is only about efficacy and safety. Period" the FDA saw efficacy when they reviewed the data for OLE and eIND, the same data they are looking at now.

Story on CytoDyn in the same article with Novavax

"Novavax concludes subject enrolment in Covid-19 vaccine trial" https://www.pharmaceutical-technology.com/news/novavax-concludes-subject-enrolment/

What? That's not a trial extension, far from it. It's not an extension at all. That was offering an additional interim look at 42 days if needed. It was never needed because the trial was filled so quickly by doctors eager for the possibility of getting Leronlimab to their patients.

They never recommended extending the trial. That's just simply untrue.

NDA pertaining to partnership negotiation??

Heading towards $5 CYDY

FDA and Amarex employees buying CYDY??

Let's take the word of the FDA. They seem to be leaning towards Leronlimab being an effective treatment against covid-19 by approving OLE and eIND. And let's take the word of the market, now that they are looking at the data CYDY share price is heading up, this is after sell the news. The price recovery is a strong indicator of positive data.

CD12 will be approved for EUA. And it will be announced sooner than people think.

We all completely agree with you that AF was paid for his hit piece against CYDY.

Not effective??!!! CytoDyn presented the FDA with data from eIND patients being treated with Leronlimab for Covid. The FDA viewed the data as very effective, so much so they granted a phase 3 trial, not the typical phase 1 or 2. If the data was not showing effectiveness or just ok it would have been a phase 2 trial.

Stall?? Two to three weeks is an unheard-of amount of time, incredibly fast actually. Typically the FDA would take months to look at data from a trial. Two to three weeks shows the urgency of the FDA wanting to get Leronlimab to the public.

The FDA does also in fact approve EUA for drugs that work. Very similar to the FDA giving approval for OLE and eIND, the reason for this approval is the FDA looked at Leronlimab's data and saw it works. Now they are looking at the same data for CD12. Leronlimab will be approved for EUA.

I'd be hesitant to call it either way. For all we know CD12 performed excellent crushing the endpoints and there are now partnerships with NDA's being discussed. What we do know is CD12 is unblinded and discussions are now ongoing. This is nothing but positive.

" if results will not be positive why discussions predicted for the next 2-3 weeks"

This was my first thought after reading today's PR. There would be no need for discussions with failed data. I view the PR as very positive.

Good observation, he skipped right over CD12. No mention of OLE approval, no mention of eIND approval, no mention of the medicare billing code. No mention of longhaulers trial. This is a classic paid hit piece, attempting to divert attention from CD12 approval.

So after Leronlimab's approval for covid-19 which approval is next longhaulers or HIV? I'm leaning towards longhaulers approved before HIV.

Did the FDA grant Leronlimab a phase 3 trial to treat covid-19 based on eIND data because it's "crap"? Did the FDA approve OLE and eIND for Leronlimab because it's "crap"?

Sorry, TD Ameritrade does indeed trade OTC stocks. There's a branch down the street from Amarex Clinical. I'm sure that's the branch where many Amarex employees buy their CYDY stock.

No, the cleaning crew was spotted down the street at TD Bank buying CYDY stock.

The stock price doesn't approve CD12. The FDA does. Stocks go up stocks go down, it's what they do. I can care less if it's red, I'll profit the same millions after approval regardless of the current price.

Leronlimab received approval for OLE and eIND to treat covid-19, after the FDA looked at the scientific data from CD12.

Just a tip for any novice investors. There's been rumors of a J&J buyout or partnership. If this type of scenario ever takes place the announcement would come after market closes with no warning, and the following market open CYDY would open at the buyout price. Just something to keep in mind.